LCA5
Lebercilin
Also known as: C6orf152, LCA5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86VQ0
- Gene
- LCA5
- Ensembl
- ENSG00000135338
- Chromosome
- 6
- Canonical length
- 697 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Primary cilium,Mitochondria,Basal body,Flagellar centriole,Mid piece
OverviewNCBI Gene
This gene encodes a protein that is thought to be involved in centrosomal or ciliary functions. Mutations in this gene cause Leber congenital amaurosis type V. Alternatively spliced transcript variants are described. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
697 residues, UniProt reviewed canonical sequence.
>Q86VQ0|LCA5
1 MGERAGSPGT DQERKAGKHH YSYLSDFETP QSSGRSSLVS SSPASVRRKN PKRQTSDGQV
61 HHQAPRKPSP KGLPNRKGVR VGFRSQSLNR EPLRKDTDLV TKRILSARLL KINELQNEVS
121 ELQVKLAELL KENKSLKRLQ YRQEKALNKF EDAENEISQL IFRHNNEITA LKERLRKSQE
181 KERATEKRVK DTESELFRTK FSLQKLKEIS EARHLPERDD LAKKLVSAEL KLDDTERRIK
241 ELSKNLELST NSFQRQLLAE RKRAYEAHDE NKVLQKEVQR LYHKLKEKER ELDIKNIYSN
301 RLPKSSPNKE KELALRKNAA CQSDFADLCT KGVQTMEDFK PEEYPLTPET IMCYENKWEE
361 PGHLTLDLQS QKQDRHGEAG ILNPIMEREE KFVTDEELHV VKQEVEKLED EWEREELDKK
421 QKEKASLLER EEKPEWETGR YQLGMYPIQN MDKLQGEEEE RLKREMLLAK LNEIDRELQD
481 SRNLKYPVLP LLPDFESKLH SPERSPKTYR FSESSERLFN GHHLQDISFS TPKGEGQNSG
541 NVRSPASPNE FAFGSYVPSF AKTSERSNPF SQKSSFLDFQ RNSMEKLSKD GVDLITRKEK
601 KANLMEQLFG ASGSSTISSK SSDPNSVASS KGDIDPLNFL PGNKGSRDQE HDEDEGFFLS
661 EGRSFNPNRH RLKHADDKPA VKAADSVEDE IEEVALRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LCA5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 16 nTPM
- choroid plexus: 14 nTPM
- retina: 13 nTPM
- fallopian tube: 9 nTPM
- testis: 6.5 nTPM
- ovary: 6.1 nTPM
Single-cell type
- choroid plexus epithelial cells: 252 nCPM
- ependymal cells: 249 nCPM
- fallopian tube ciliated cells: 236 nCPM
- respiratory ciliated cells: 212 nCPM
- endometrial ciliated cells: 114 nCPM
- epididymal efferent duct ciliated cells: 97 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 40 nTPM
- hippocampal formation: 17 nTPM
- midbrain: 17 nTPM
- white matter: 16 nTPM
- spinal cord: 16 nTPM
- medulla oblongata: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LCA5.
Disease | AllUniProt
Conditions LCA5 is implicated in, by any mechanism.
- Leber congenital amaurosis 5 (LCA5) MIM:604537
Disease | GeneticClinVar
167 pathogenic / likely-pathogenic of 918 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.62
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LCA5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LCA5 as an antibody target. Whether an autoantibody or antibody against LCA5 could matter depends on whether native LCA5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LCA5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LCA5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...